Literature DB >> 24318592

Extramedullary T-lymphoid blast crisis of an ETV6/ABL1-positive myeloproliferative neoplasm with t(9;12)(q34;p13) and t(7;14)(p13;q11.2).

Katsuya Yamamoto1, Kimikazu Yakushijin, Yuji Nakamachi, Yoshiharu Miyata, Yukinari Sanada, Yasuhiro Tanaka, Atsuo Okamura, Seiji Kawano, Yoshitake Hayashi, Hiroshi Matsuoka, Hironobu Minami.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24318592     DOI： 10.1007/s00277-013-1975-y

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  7 in total

1.  ETV6-ABL1 fusion combined with monosomy 7 in childhood B-precursor acute lymphoblastic leukemia.

Authors:  Suguru Uemura; Noriyuki Nishimura; Daiichiro Hasegawa; Akemi Shono; Kimiyoshi Sakaguchi; Hisayuki Matsumoto; Yuji Nakamachi; Jun Saegusa; Takehito Yokoi; Teppei Tahara; Akihiro Tamura; Nobuyuki Yamamoto; Atsuro Saito; Aiko Kozaki; Kenji Kishimoto; Toshiaki Ishida; Nanako Nino; Satoru Takafuji; Takeshi Mori; Kazumoto Iijima; Yoshiyuki Kosaka
Journal:  Int J Hematol       Date:  2017-11-24       Impact factor: 2.490

2.  Characterization of leukemias with ETV6-ABL1 fusion.

Authors:  Marketa Zaliova; Anthony V Moorman; Giovanni Cazzaniga; Martin Stanulla; Richard C Harvey; Kathryn G Roberts; Sue L Heatley; Mignon L Loh; Marina Konopleva; I-Ming Chen; Olga Zimmermannova; Claire Schwab; Owen Smith; Marie-Joelle Mozziconacci; Christian Chabannon; Myungshin Kim; J H Frederik Falkenburg; Alice Norton; Karen Marshall; Oskar A Haas; Julia Starkova; Jan Stuchly; Stephen P Hunger; Deborah White; Charles G Mullighan; Cheryl L Willman; Jan Stary; Jan Trka; Jan Zuna
Journal:  Haematologica       Date:  2016-05-26       Impact factor: 9.941

3.  An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia.

Authors:  O Zimmermannova; E Doktorova; J Stuchly; V Kanderova; D Kuzilkova; H Strnad; J Starkova; M Alberich-Jorda; J H F Falkenburg; J Trka; J Petrak; J Zuna; M Zaliova
Journal:  Oncogene       Date:  2017-06-26       Impact factor: 9.867

4.  Significance of ETV6 rearrangement in acute promyelocytic leukemia with t(15;17)/promyelocytic leukemia/retinoic acid receptor alpha.

Authors:  N A Gao; Wen-Zheng Yu; Xue-Xia Wang; Jian-Rong Sun; Ning Yu; Zeng-Yan Liu; Xiao-Dan Liu; Ren-Tong Liu; Rui Feng; Bu-Tong Ding; Tan Sang; Nong-Jian Guo
Journal:  Oncol Lett       Date:  2016-05-06       Impact factor: 2.967

5.  A novel three-way rearrangement involving ETV6 (12p13) and ABL1 (9q34) with an unknown partner on 3p25 resulting in a possible ETV6-ABL1 fusion in a patient with acute myeloid leukemia: a case report and a review of the literature.

Authors:  Carlos A Tirado; Ken Siangchin; David S Shabsovich; Maryam Sharifian; Gary Schiller
Journal:  Biomark Res       Date:  2016-08-25

6.  [Acute myeloid leukemia with co-expression of TEL-ABL1 and NUP98-HOXA9 fusion genes: a case report and literature review].

Authors:  C Y Wu; Y L Li; X Y Dong; L Zhang; B J Shang; W Li; Z B Li; L Zhang; Z M Zhu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-07-14

7.  Myeloid/lymphoid neoplasms with eosinophilia/ basophilia and ETV6-ABL1 fusion: cell-of-origin and response to tyrosine kinase inhibition.

Authors:  JinJuan Yao; Lianrong Xu; Umut Aypar; Howard J Meyerson; Dory Londono; Qi Gao; Jeeyeon Baik; James Dietz; Ryma Benayed; Allison Sigler; Mariko Yabe; Ahmet Dogan; Maria E Arcila; Mikhail Roshal; Yanming Zhang; Michael J Mauro; Wenbin Xiao
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.